No guidance ?? The addressable market looks pretty massive to me and now with CE mark , RHT will be re rated worth in the $billions!
With an estimated global prevalence of between 24-30%1 , NAFLD affects up to 2.3 billion people, a figure expected to grow year-on-year. Of these, about 470 million people (or 20%) will develop NASH2 .
- Forums
- ASX - By Stock
- RHT
- Ann: HepaFat-AI Receives TGA Approval
Ann: HepaFat-AI Receives TGA Approval, page-45
Featured News
Add RHT (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
-0.001(1.56%) |
Mkt cap ! $28.15M |
Open | High | Low | Value | Volume |
6.2¢ | 6.3¢ | 5.9¢ | $37.73K | 625.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 223668 | 5.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.3¢ | 99999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 223668 | 0.059 |
1 | 100000 | 0.058 |
1 | 80000 | 0.057 |
1 | 103464 | 0.055 |
1 | 200000 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 99999 | 1 |
0.064 | 140246 | 1 |
0.065 | 75000 | 1 |
0.068 | 100000 | 1 |
0.069 | 65000 | 1 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |